These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 475846)

  • 21. Cyclophosphamide-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of visceral pain.
    Boucher M; Meen M; Codron JP; Coudore F; Kemeny JL; Eschalier A
    J Urol; 2000 Jul; 164(1):203-8. PubMed ID: 10840460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperbaric oxygen treatment for experimental cyclophosphamide-induced hemorrhagic cystitis.
    Hader JE; Marzella L; Myers RA; Jacobs SC; Naslund MJ
    J Urol; 1993 Jun; 149(6):1617-21. PubMed ID: 8501819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of reactive metabolites in drug-induced teratogenesis.
    Hales BF; Slott VL
    Prog Clin Biol Res; 1987; 253():181-91. PubMed ID: 3432286
    [No Abstract]   [Full Text] [Related]  

  • 24. Nitric oxide and NK(1)-tachykinin receptors in cyclophosphamide-induced cystitis, in rats.
    Alfieri AB; Cubeddu LX
    J Pharmacol Exp Ther; 2000 Nov; 295(2):824-9. PubMed ID: 11046124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetic toxicity of cyclophosphamide and its metabolites in vitro.
    Au W; Sokova OI; Kopnin B; Arrighi FE
    Cytogenet Cell Genet; 1980; 26(2-4):108-16. PubMed ID: 7389408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenomena of adaptation in rats continuously exposed to low concentrations of acrolein.
    Bouley G; Dubreuil A; Godin J; Boisset M; Boudène C
    Ann Occup Hyg; 1976 Jul; 19(1):27-32. PubMed ID: 970842
    [No Abstract]   [Full Text] [Related]  

  • 27. Acrolein mercapturates: synthesis, characterization, and assessment of their role in the bladder toxicity of cyclophosphamide.
    Ramu K; Fraiser LH; Mamiya B; Ahmed T; Kehrer JP
    Chem Res Toxicol; 1995 Jun; 8(4):515-24. PubMed ID: 7548731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of diuretics on urinary general base catalytic activity and cyclophosphamide-induced bladder toxicity.
    Sladek NE; Smith PC; Bratt PM; Low JE; Powers JF; Borch RF; Coveney JR
    Cancer Treat Rep; 1982 Nov; 66(11):1889-1900. PubMed ID: 7139634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of thiols on toxicity and carcinostatic activity of cyclophosphamide.
    Gurtoo HL; Marinello AJ; Berrigan MJ; Bansal SK; Paul B; Pavelic ZP; Struck RF
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):35-45. PubMed ID: 6836326
    [No Abstract]   [Full Text] [Related]  

  • 30. Functional, histological structure and mastocytes alterations in rat urinary bladders following acute and [corrected] chronic cyclophosphamide treatment.
    Juszczak K; Gil K; Wyczolkowski M; Thor PJ
    J Physiol Pharmacol; 2010 Aug; 61(4):477-82. PubMed ID: 20814076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of nitric oxide on the primary bladder afferent activities of the rat with and without intravesical acrolein treatment.
    Aizawa N; Igawa Y; Nishizawa O; Wyndaele JJ
    Eur Urol; 2011 Feb; 59(2):264-71. PubMed ID: 21067861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effectiveness of N-acetylcysteine in isolated hepatocytes, against the toxicity of paracetamol, acrolein, and paraquat.
    Dawson JR; Norbeck K; Anundi I; Moldéus P
    Arch Toxicol; 1984 Mar; 55(1):11-5. PubMed ID: 6732501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclophosphamide cystitis and bladder cancer. A hypothesis.
    Cox PJ
    Eur J Cancer (1965); 1979 Aug; 15(8):1071-2. PubMed ID: 510344
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study.
    Freedman A; Ehrlich RM; Ljung BM
    J Urol; 1984 Sep; 132(3):580-2. PubMed ID: 6433044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the cyclophosphamide metabolite acrolein in mammalian limb bud cultures.
    Stahlmann R; Bluth U; Neubert D
    Arch Toxicol; 1985 Aug; 57(3):163-7. PubMed ID: 3933456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amelioration of cyclophosphamide-induced cystitis.
    Primack A
    J Natl Cancer Inst; 1971 Jul; 47(1):223-7. PubMed ID: 4998859
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemoprotection against cyclophosphamide-induced urotoxicity: comparison of nine thiol protective agents.
    Roberts JC; Francetic DJ; Zera RT
    Anticancer Res; 1994; 14(2A):389-95. PubMed ID: 8017838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclophosphamide-induced Down-Regulation of Uroplakin II in the Mouse Urinary Bladder Epithelium is Prevented by S-Allyl Cysteine.
    Abdi SA; Najmi AK; Raisuddin S
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):598-603. PubMed ID: 27234646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of penicillamine and related thiols on cyclophosphamide-induced cystitis and bone marrow suppression.
    Christophidis N; Cosolo W; Louis WJ; Louis CJ
    Int J Tissue React; 1984; 6(6):493-8. PubMed ID: 6530353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbenoxolone inhibits TRPV4 channel-initiated oxidative urothelial injury and ameliorates cyclophosphamide-induced bladder dysfunction.
    Zhang X; Gao S; Tanaka M; Zhang Z; Huang Y; Mitsui T; Kamiyama M; Koizumi S; Fan J; Takeda M; Yao J
    J Cell Mol Med; 2017 Sep; 21(9):1791-1802. PubMed ID: 28244642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.